|
ZBTB38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.984600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.815700E-03 |
| Normal-vs-Stage2 |
2.656200E-02 |
| Normal-vs-Stage3 |
7.82380000000638E-05 |
| Normal-vs-Stage4 |
3.76840000000378E-05 |
| Stage1-vs-Stage2 |
9.701800E-01 |
| Stage1-vs-Stage3 |
7.887500E-02 |
| Stage1-vs-Stage4 |
3.203900E-02 |
| Stage2-vs-Stage3 |
2.516400E-01 |
| Stage2-vs-Stage4 |
1.039400E-01 |
| Stage3-vs-Stage4 |
4.333200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.183500E-04 |
| Normal-vs-AfricanAmerican |
1.833600E-01 |
| Normal-vs-Asian |
8.983600E-03 |
| Caucasian-vs-AfricanAmerican |
2.928000E-01 |
| Caucasian-vs-Asian |
8.577400E-01 |
| AfricanAmerican-vs-Asian |
4.155200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92219999999699E-05 |
| Normal-vs-Female |
1.682400E-03 |
| Male-vs-Female |
1.603040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.103520E-02 |
| Normal-vs-Age(41-60Yrs) |
1.647430E-04 |
| Normal-vs-Age(61-80Yrs) |
1.972380E-04 |
| Normal-vs-Age(81-100Yrs) |
1.969580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.118790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.232050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.380000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.365400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.632200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.976800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.636200E-02 |
| Classical-VS-Follicular |
9.318500E-03 |
| Classical-VS-Other |
6.552300E-02 |
| Classical-VS-Normal |
1.190090E-02 |
| Tall-VS-Follicular |
7.881000E-01 |
| Tall-VS-Other |
3.664200E-01 |
| Tall-VS-Normal |
4.802300E-04 |
| Follicular-VS-Other |
3.475000E-01 |
| Follicular-VS-Normal |
1.022470E-04 |
| Other-VS-Normal |
5.216200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.562900E-04 |
| Normal-vs-N1 |
4.25870000000383E-05 |
| N0-vs-N1 |
2.317800E-01 |
|
|
